PL2542250T3 - Mikropęcherzyki (mvs) pochodzące z dorosłych komórek macierzystych do zastosowania w terapeutycznym leczeniu choroby nowotworowej - Google Patents

Mikropęcherzyki (mvs) pochodzące z dorosłych komórek macierzystych do zastosowania w terapeutycznym leczeniu choroby nowotworowej

Info

Publication number
PL2542250T3
PL2542250T3 PL11705585T PL11705585T PL2542250T3 PL 2542250 T3 PL2542250 T3 PL 2542250T3 PL 11705585 T PL11705585 T PL 11705585T PL 11705585 T PL11705585 T PL 11705585T PL 2542250 T3 PL2542250 T3 PL 2542250T3
Authority
PL
Poland
Prior art keywords
microvesicles
mvs
derived
stem cells
therapeutic treatment
Prior art date
Application number
PL11705585T
Other languages
English (en)
Inventor
Stefania Bruno
Sanchez Maria Beatriz Herrera
Valentina Fonsato
Giovanni Camussi
Ciro Tetta
Original Assignee
Fresenius Medical Care Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fresenius Medical Care Deutschland Gmbh filed Critical Fresenius Medical Care Deutschland Gmbh
Publication of PL2542250T3 publication Critical patent/PL2542250T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL11705585T 2010-03-02 2011-02-28 Mikropęcherzyki (mvs) pochodzące z dorosłych komórek macierzystych do zastosowania w terapeutycznym leczeniu choroby nowotworowej PL2542250T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10425052A EP2363136A1 (en) 2010-03-02 2010-03-02 Microvesicles (MVs) derived from adult stem cells for use in the therapeutic treatment of a tumor disease
PCT/EP2011/052945 WO2011107437A1 (en) 2010-03-02 2011-02-28 Microvesicles (mvs) derived from adult stem cells for use in the therapeutic treatment of a tumor disease
EP11705585.5A EP2542250B1 (en) 2010-03-02 2011-02-28 Microvesicles (mvs) derived from adult stem cells for use in the therapeutic treatment of a tumor disease

Publications (1)

Publication Number Publication Date
PL2542250T3 true PL2542250T3 (pl) 2016-04-29

Family

ID=42306621

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11705585T PL2542250T3 (pl) 2010-03-02 2011-02-28 Mikropęcherzyki (mvs) pochodzące z dorosłych komórek macierzystych do zastosowania w terapeutycznym leczeniu choroby nowotworowej

Country Status (10)

Country Link
US (4) US9717760B2 (pl)
EP (2) EP2363136A1 (pl)
JP (1) JP5841952B2 (pl)
CN (1) CN102781454B (pl)
DK (1) DK2542250T3 (pl)
ES (1) ES2554492T3 (pl)
HU (1) HUE026292T2 (pl)
PL (1) PL2542250T3 (pl)
PT (1) PT2542250E (pl)
WO (1) WO2011107437A1 (pl)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2363136A1 (en) * 2010-03-02 2011-09-07 Fresenius Medical Care Deutschland GmbH Microvesicles (MVs) derived from adult stem cells for use in the therapeutic treatment of a tumor disease
ES2906750T3 (es) 2010-05-12 2022-04-20 Prokidney Células renales bioactivas
ITRM20110403A1 (it) * 2011-07-28 2013-01-29 Ospedale Pediatrico Bambino Gesu Microvescicole isolate da cellule mesenchimali come agenti immunosoppressori.
CN102357071B (zh) * 2011-10-26 2013-10-23 重庆医科大学附属儿童医院 载紫杉醇纳米微泡及其制备方法
PL2785359T3 (pl) * 2011-11-30 2018-12-31 Astellas Institute For Regenerative Medicine Mezenchymalne komórki zrębowe i związane z nimi zastosowania
US8961956B2 (en) 2011-11-30 2015-02-24 Ocata Therapeutics, Inc. Mesenchymal stromal cells and uses related thereto
US11286463B2 (en) 2012-03-08 2022-03-29 Advanced ReGen Medical Technologies, LLC Reprogramming of aged adult stem cells
CN104471059B (zh) 2012-07-12 2018-04-17 珠海横琴爱姆斯坦生物科技有限公司 人胚胎干细胞衍生的间充质样干细胞、方法及其应用
US10772911B2 (en) 2013-12-20 2020-09-15 Advanced ReGen Medical Technologies, LLC Cell free compositions for cellular restoration and methods of making and using same
US20150174166A1 (en) 2013-12-20 2015-06-25 Advanced ReGen Medical Technologies, LLC Compositions for Cellular Restoration and Methods of Making and Using Same
EP3122333A4 (en) * 2014-03-24 2017-11-29 Advanced Regen Medical Technologies, LLC Cell free compositions for cellular restoration and methods of making and using same
US10538738B2 (en) * 2014-05-19 2020-01-21 Eleftherios Papoutsakis Megakaryocytic particles and microparticles for cell therapy and fate modification of stem and progenitor cells
CN109475645A (zh) 2016-04-29 2019-03-15 先进瑞金医疗技术有限公司 微rna组合物及其制备和使用方法
CA3085662A1 (en) 2017-12-14 2019-06-20 Unicyte Ev Ag Pharmaceutical carriers containing mirnas for use in the treatment of renal cancer
EP3740576A4 (en) 2018-01-18 2021-10-20 Advanced Regen Medical Technologies, LLC THERAPEUTIC COMPOSITIONS AND THEIR PREPARATION AND USE METHODS
WO2019197442A1 (en) * 2018-04-12 2019-10-17 Unicyte Ev Ag A combination of active ingredients for the treatment of tumor
CN111494417B (zh) * 2020-02-10 2024-04-09 寇晓星 诱导性细胞外囊泡在制备治疗肿瘤药物中的应用
US12697307B2 (en) 2020-05-11 2026-08-04 Strm.Bio Incorporated Compositions and methods related to megakaryocyte-derived extracellular vesicles
KR102601831B1 (ko) * 2020-09-23 2023-11-14 대한민국 고형암 증식 억제 효과를 갖는 개과동물의 엑소좀
WO2022087505A1 (en) 2020-10-23 2022-04-28 Strm.Bio Incorporated Compositions and methods related to megakaryocyte-derived extracellular vesicles for treating myeloproliferative neoplasms
AU2022264498A1 (en) 2021-04-26 2023-09-28 Strm.Bio Incorporated Compositions and methods related to megakaryocyte-derived extracellular vesicles for fanconi anemia
EP4534649A1 (en) * 2023-10-03 2025-04-09 Unicyte AG A method of qualifying as pharmaceutically active a batch of undifferentiated adult stem cells having the potential to differentiate along the hepatic lineage

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6088613A (en) * 1989-12-22 2000-07-11 Imarx Pharmaceutical Corp. Method of magnetic resonance focused surgical and therapeutic ultrasound
AU5871898A (en) * 1997-01-30 1998-08-25 Andaris Limited Microparticles and their use in cancer treatment
AU753196B2 (en) * 1998-02-09 2002-10-10 Bracco Research S.A. Targeted delivery of biologically active media
US20020177551A1 (en) * 2000-05-31 2002-11-28 Terman David S. Compositions and methods for treatment of neoplastic disease
US7128903B2 (en) * 2001-10-03 2006-10-31 Innovative Pharmaceutical Concepts (Ipc) Inc. Pharmaceutical preparations useful for treating tumors and lesions of the skin and the mucous membranes and methods and kits using same
WO2005121369A2 (en) * 2004-06-02 2005-12-22 Sourcepharm, Inc. Rna-containing microvesicles and methods therefor
US8148335B2 (en) * 2004-06-23 2012-04-03 Children's Hospital & Research Center Oakland De-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy
GB0501129D0 (en) * 2005-01-19 2005-02-23 Ribostem Ltd Method of treatment by administration of RNA
WO2006126219A1 (en) 2005-05-26 2006-11-30 Fresenius Medical Care Deutschland G.M.B.H. Liver progenitor cells
US20090000641A1 (en) 2007-06-28 2009-01-01 Applied Materials, Inc. Methods and apparatus for cleaning deposition chamber parts using selective spray etch
BRPI0816852A2 (pt) * 2007-09-14 2017-06-06 Univ Ohio State Res Found método de diagnosticar ou prognosticar doença ou desordem em sujeito, biomarcador, método para determinar e/ou prever se sujeito tem diferenciação da desordem, biomarcador para desordem pulmonar, método para diagnosticar se sujeito tem, ou está em risco de desenvolver doença ou desordem, método de inibir a proliferação de doença ou desordem e método para identificar agente terapêutico do câncer.
JP5719171B2 (ja) * 2007-10-15 2015-05-13 フレゼニウス メディカル ケア ドイッチェランド ゲゼルシャフト ミット ベシュレンクテル ハフツング 内皮細胞移植、特に膵島移植による糖尿病の処置におけるアジュバント活性を有する医薬を調製するための微小胞（ｍｖ）の使用、および関連方法
CN101854941B (zh) * 2007-10-29 2013-03-27 弗雷森纽斯医疗护理德国有限责任公司 衍生自干细胞的微泡(MVs)用于制备用于受损或损伤组织或器官的内皮/上皮再生的药物的用途、以及相关体外和体内方法
NZ586497A (en) * 2008-01-04 2012-07-27 Lydac Neuroscience Ltd Microvesicles
PT2254586E (pt) * 2008-02-22 2015-05-18 Agency Science Tech & Res Partículas de células estaminais mesenquimais
EP2186883A1 (en) 2008-11-04 2010-05-19 Fresenius Medical Care An isolated multipotent mesenchymal stem cell from human adult glomeruli (hGL-MSC), a method of preparing thereof and uses thereof in the regenerative medicine of the kidney
EP2363136A1 (en) * 2010-03-02 2011-09-07 Fresenius Medical Care Deutschland GmbH Microvesicles (MVs) derived from adult stem cells for use in the therapeutic treatment of a tumor disease

Also Published As

Publication number Publication date
WO2011107437A1 (en) 2011-09-09
DK2542250T3 (en) 2015-12-07
EP2542250B1 (en) 2015-08-26
EP2542250A1 (en) 2013-01-09
CN102781454B (zh) 2015-12-16
PT2542250E (pt) 2015-12-09
US20230248774A1 (en) 2023-08-10
HUE026292T2 (en) 2016-05-30
CN102781454A (zh) 2012-11-14
JP2013520971A (ja) 2013-06-10
US10105395B2 (en) 2018-10-23
US9717760B2 (en) 2017-08-01
JP5841952B2 (ja) 2016-01-13
EP2363136A1 (en) 2011-09-07
US20120321723A1 (en) 2012-12-20
US20170348356A1 (en) 2017-12-07
ES2554492T3 (es) 2015-12-21
US20190060369A1 (en) 2019-02-28

Similar Documents

Publication Publication Date Title
PT2542250E (pt) Microvesículas (mvs) derivadas de células estaminais adultas para uso no tratamento terapêutico de uma doença tumoral
AP3155A (en) Methods of administering pirfenidone therapy
IL234624A0 (en) Compounds for use as a drug to treat a solid tumor in a patient
PL2714059T3 (pl) Leczenie bólu z użyciem komórek macierzystych łożyska
EP2427250A4 (en) THERAPEUTIC BODY STRAP
IL232251B (en) Pharmaceutical combination for use in the treatment of type 2 diabetes patients
ZA201107215B (en) Therapeutic agents for the treatment of diseases associated with undersired cell proliferation
IL217901B (en) Use of laquinimod or a laquinimod salt in the manufacture of a drug for the treatment of bdnf-related diseases
ZA201208646B (en) Pharmaceutical combination for the treatment of pain
IL260078B (en) Therapy used to treat Gaucher disease
GB0906159D0 (en) Drug combination for the treatment of proteostatic diseases
GB201002243D0 (en) Respiratory disease treatment
IL215831A (en) A drug containing allopurinol for use in the treatment of hand-foot skin reaction
ZA201404000B (en) Fluid-injection system for medical use in the vascular system of a patient
IL275636A (en) Medical combination for cancer treatment
GB201002224D0 (en) Respiratory disease treatment
ZA201402477B (en) Compounds for use in the treatment of alzheimer's disease
GB201114289D0 (en) Flurbiprofen and related compounds for the treatment of skin diseases
IL216717A (en) Use of benzidamine in the manufacture of a drug for the treatment of p40-dependent diseases
ZA201308176B (en) Therapeutic treatment
PL2424602T3 (pl) System do dostarczania środka leczniczego do skóry pacjenta
GB201118421D0 (en) Appliance for administering pain relieving therapy
IL204097A0 (en) Medicine for the treatment of skin cancer
GB201001903D0 (en) Respiratory disease treatment
GB2477540A8 (en) Respiratory disease treatment